Mary T. Szela, Director at Absci Corp (ABSI), bought 12,900 shares at $11.54 ($149K) on 2026-06-30, disclosed to the SEC on 2026-07-06.
Director Mary T. Szela purchased 12,900 shares at $11.54, marking the largest insider purchase in Absci Corp's history. This bullish signal arrives on the heels of positive Phase 1 data for the hair loss drug ABS-201 and a $100 million equity raise.
Absci stock trades at $6.80, having surged 132.88% over the last 90 days and 145.49% over the past year, though it remains 7.98% below its 52-week high of $7.39.
Something here stands out, but not much.
| Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |
| TLSI | BUY | 2025-01-29 | $50K | — | Filing → |